Search Results - "Cachot, Amélie"

Optimized combinatorial pMHC class II multimer labeling for precision immune monitoring of tumor-specific CD4 T cells in patients by Rockinger, Georg Alexander, Guillaume, Philippe, Cachot, Amélie, Saillard, Margaux, Speiser, Daniel E, Coukos, Georges, Harari, Alexandre, Romero, Pedro J, Schmidt, Julien, Jandus, Camilla

“…BackgroundWith immunotherapy gaining increasing approval for treatment of different tumor types, scientists rely on cutting edge methods for the monitoring of…”
Get full text

510 Helping the killers: innovative cancer immunotherapy harnessing quasi-universal tumor antigen-specific CD4 T cells by Saillard, Margaux, Cachot, Amelie, Rockinger, Georg Alexander, Guillaume, Philippe, Schmidt, Julien, Harari, Alexandre, Jandus, Camilla, Romero, Pedro

“…BackgroundWhile cancer immunotherapy has mainly focused on exploiting CD8 T cells given their role in the direct elimination of tumor cells, increasing…”
Get full text

545 Tumor-specific cytolytic CD4 T cells mediate protective immunity against human cancer by Cachot, Amélie, Bilous, Mariia, Liu, Yen-Cheng, Li, Xiaokang, Rockinger, Alexander, Saillard, Margaux, Wyss, Tania, Guillaume, Philippe, Schmidt, Julien, Genolet, Raphael, Protti, Maria Pia, Reith, Walter, Leval, Laurence De, Ioannidou, Kalliopi, Coukos, George, Harari, Alexandre, Speiser, Daniel, Mathis, Alexander, Gfeller, David, Altug, Hatice, Romero, Pedro, Jandus, Camilla

“…BackgroundCD4 T cells have been implicated in cancer immunity for their helper functions. However, their direct cytotoxic potential remains elusive in cancer…”
Get full text

Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer by Cachot, Amélie, Bilous, Mariia, Liu, Yen-Cheng, Li, Xiaokang, Saillard, Margaux, Cenerenti, Mara, Rockinger, Georg Alexander, Wyss, Tania, Guillaume, Philippe, Schmidt, Julien, Genolet, Raphaël, Ercolano, Giuseppe, Protti, Maria Pia, Reith, Walter, Ioannidou, Kalliopi, de Leval, Laurence, Trapani, Joseph A, Coukos, George, Harari, Alexandre, Speiser, Daniel E, Mathis, Alexander, Gfeller, David, Altug, Hatice, Romero, Pedro, Jandus, Camilla

“…CD4 T cells have been implicated in cancer immunity for their helper functions. Moreover, their direct cytotoxic potential has been shown in some patients with…”
Get full text

High-throughput Screening of Human Tumor Antigen-specific CD4 T Cells, Including Neoantigen-reactive T Cells by Costa-Nunes, Carla, Cachot, Amélie, Bobisse, Sara, Arnaud, Marion, Genolet, Raphael, Baumgaertner, Petra, Speiser, Daniel E, Sousa Alves, Pedro M, Sandoval, Federico, Adotévi, Olivier, Reith, Walter, Protti, Maria Pia, Coukos, George, Harari, Alexandre, Romero, Pedro, Jandus, Camilla

“…Characterization of tumor antigen-specific CD4 T-cell responses in healthy donors and malignant melanoma patients using an amplified T-cell library screening…”
Get full text

Effects of postmortem delays on protein composition and oxidation by ElHajj, Zeinab, Cachot, Amélie, Müller, Terry, Riederer, Irène M, Riederer, Beat M

“…Graphical abstract…”
Get full text

Vaccination with long NY-ESO-1 79-108 peptide and CpG-B leads to robust activation of CD4 and CD8 T cell responses in stage III/IV melanoma patients, and a new HLA-DR7 epitope by Baumgartner, Petra, Nunes, Carla Costa, Cachot, Amñlie, Hajjami, Hñlène Maby-El, Cagnon, Laurène, Braun, Marion, Derrñ, Laurent, Rivals, Jean-Paul, Rimoldi, Donata, Romano, Emanuela, Michielin, Olivier, Romero, Pedro, Jandus, Camilla, Speiser, Daniel E

“…Although promising, the combination of long synthetic peptides and CpG-B oligodeoxynucleotides has not yet been tested as cancer vaccine. In this Phase I…”
Get full text